Berlin - Delayed Quote EUR

Iovance Biotherapeutics Inc (2LB.BE)

Compare
7.01 -0.18 (-2.56%)
At close: December 30 at 8:03:16 AM GMT+1
Loading Chart for 2LB.BE
DELL
  • Previous Close 7.20
  • Open 7.01
  • Bid --
  • Ask --
  • Day's Range 7.01 - 7.01
  • 52 Week Range 6.69 - 16.50
  • Volume 0
  • Avg. Volume 0
  • Market Cap (intraday) --
  • Beta (5Y Monthly) --
  • PE Ratio (TTM) --
  • EPS (TTM) --
  • Earnings Date Feb 26, 2025 - Mar 3, 2025
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est --

Recent News: 2LB.BE

View More

Performance Overview: 2LB.BE

Trailing total returns as of 12/31/2024, which may include dividends or other distributions. Benchmark is

.

YTD Return

2LB.BE
10.51%
S&P 500
23.31%

1-Year Return

2LB.BE
10.51%
S&P 500
23.31%

3-Year Return

2LB.BE
58.80%
S&P 500
23.08%

5-Year Return

2LB.BE
71.72%
S&P 500
82.59%

Compare To: 2LB.BE

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: 2LB.BE

View More

Valuation Measures

As of 12/30/2024
  • Market Cap

    2.10B

  • Enterprise Value

    1.79B

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    22.35

  • Price/Book (mrq)

    2.88

  • Enterprise Value/Revenue

    20.55

  • Enterprise Value/EBITDA

    --

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    --

  • Return on Assets (ttm)

    --

  • Return on Equity (ttm)

    --

  • Revenue (ttm)

    --

  • Net Income Avi to Common (ttm)

    --

  • Diluted EPS (ttm)

    --

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    --

  • Total Debt/Equity (mrq)

    --

  • Levered Free Cash Flow (ttm)

    --

Research Analysis: 2LB.BE

View More